FDA Grants De Novo Classification to Neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes (Business Wire)
UF startup neuropacs™ Corp. received FDA De Novo classification for its diffusion MRI–based software designed to assist clinicians in evaluating Parkinsonian syndromes.